M33 Growth I L.P. is Director of Oncology Institute, Inc.. Currently has a direct ownership of 14 Million shares of TOI, which is worth approximately $35.7 Million. The most recent transaction as insider was on Jun 05, 2025, when has been sold 673,676 shares (Common Stock) at a price of $3.05 per share, resulting in proceeds of $2,054,711. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14M
15.04% 3M change
n/a 12M change
Total Value Held $35.7 Million

M33 Growth I L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2025
SELL
Open market or private sale
$2,054,711 $3.05 p/Share
673,676 Reduced 4.61%
13,950,557 Common Stock
May 20 2025
SELL
Open market or private sale
$4,868,428 $2.71 p/Share
1,796,468 Reduced 10.94%
14,624,233 Common Stock
Mar 26 2025
BUY
Grant, award, or other acquisition
$2,825,573 $1.04 p/Share
2,716,898 Added 14.2%
16,420,701 Common Stock
MGI

M33 Growth I L.P.

Director
Boston, MA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI